Physician profile
Gabriel Lang
NPI 1437468857
$38,796.21
in general payments reported to CMS, 2019-2025
12 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $13.00 · 2021: $189 · 2022: $9,396 · 2023: $12K · 2024: $1,414 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $3,465 · Travel and Lodging: $2,762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,720.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,625.00 |
| Food and Beverage | $3,465.33 |
| Travel and Lodging | $2,761.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13,775.09 | 2019-2025 | General - Therapies, Exalt Model D, Wallflex Duodenal |
| US Endoscopy | $10,000.00 | 2023 | |
| Ambu Innovation Gmbh | $8,754.42 | 2022 | |
| Conmed Corporation | $2,028.63 | 2023-2025 | Gore Viabil, Conmed Biliary, Conmed Generators |
| Steris Corporation | $1,764.02 | 2023-2025 | |
| Ambu INC. | $916.89 | 2021-2024 | |
| Olympus America INC. | $520.36 | 2019-2025 | Gastrointestinal Videoscope, Evis Exera III Colonovideoscope, Evis Exera III Video System Center |
| Medtronic, INC. | $486.56 | 2021-2025 | Prodigi, Beacon |
| Cook Medical LLC | $372.38 | 2019-2025 | Hemospray, Fusion |
| Erbe USA INC | $140.17 | 2023 | Erbe Vio3 |
| Braintree Laboratories, INC. | $24.69 | 2019 | |
| Covidien LP | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.